Suppr超能文献

成功地为一名患有特发性再生障碍性贫血的终末期肾衰竭患者引入腹膜透析。

Successful Introduction of Peritoneal Dialysis in an End-stage Renal Failure Patient with Idiopathic Aplastic Anemia.

作者信息

Suzuki Yasuhiro, Mizuno Masashi, Sakata Fumiko, Kojima Hiroshi, Sato Yuka, Kishimoto Mayuko, Suzuki Nobuaki, Kinashi Hiroshi, Saito Shoji, Katsuno Takayuki, Kosugi Tomoki, Maruyama Shoichi, Murata Makoto, Kiyoi Hitoshi, Ito Yasuhiko

机构信息

Renal Replacement Therapy, Nagoya University Graduate School of Medicine, Japan.

Division of Nephrology, Nagoya University Graduate School of Medicine, Japan.

出版信息

Intern Med. 2020;59(5):683-687. doi: 10.2169/internalmedicine.3775-19. Epub 2020 Mar 1.

Abstract

A 45-year-old man with idiopathic aplastic anemia required renal replacement therapy (RRT) due to end-stage renal disease (ESRD). We succeeded in inserting the peritoneal dialysis (PD) catheter under cover of frequent red blood cell and platelet infusions because of severe pancytopenia. During the one-year period after starting PD using an ultraviolet-ray sterilization device, he developed severe leukopenia but no PD-related peritonitis or exit site/tunnel infection until he died of pneumonia. This case suggests that PD might be a suitable choice as RRT in ESRD patients with aplastic anemia, even in those with severe pancytopenia.

摘要

一名45岁的特发性再生障碍性贫血男性患者因终末期肾病(ESRD)需要肾脏替代治疗(RRT)。由于严重全血细胞减少,在频繁输注红细胞和血小板的掩护下,我们成功插入了腹膜透析(PD)导管。在使用紫外线消毒装置开始腹膜透析后的一年时间里,他出现了严重的白细胞减少,但在死于肺炎之前未发生与腹膜透析相关的腹膜炎或出口处/隧道感染。该病例表明,对于再生障碍性贫血的ESRD患者,即使是严重全血细胞减少的患者,腹膜透析也可能是肾脏替代治疗的合适选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3be/7086332/ce3194cf2b7f/1349-7235-59-0683-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验